Clinical Trials on Refractory Breast Carcinoma in Germany

Total 2229 results

Institut für Klinische Krebsforschung IKF GmbH...

Active, not recruiting

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC)

Germany
University Women's Hospital Tübingen
National Center for Tumor Diseases (NCT), University Hospital Heidelberg,... and other collaborators

Unknown

E-Health Portal for Individualized Treatment Monitoring and Patient Engagement in Oncology Research

Breast Cancer Metastatic

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Eli Lilly and Company; Trium Analysis Online GmbH

Completed

Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Therapy (RAMOS)

Squamous Cell Carcinoma of the Esophagus

Germany
Philips Healthcare

Completed

Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM)

Breast Cancer

United States, Germany
Novartis Pharmaceuticals
Breast International Group; German Breast Group; SOLTI Breast Cancer Research...

Completed

NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer (NeoPHOEBE)

HER2-positive Newly Diagnosed, Primary Breast Cancer

Austria, Spain, Australia, Germany
AIO-Studien-gGmbH
Bristol-Myers Squibb

Completed

A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck (OPTIM)

Carcinoma, Squamous Cell of Head and Neck | Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Germany
German Cancer Research Center
University Hospital Heidelberg; University Hospital Dresden

Not yet recruiting

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients With AML (GALAXY33)

Relapsed/Refractory Acute Myeloid Leukemia (AML)

Germany
University Hospital Tuebingen
Robert Bosch Gesellschaft für Medizinische Forschung mbH

Completed

Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial (WIn-HFS)

Breast Cancer | Hand-Foot Syndrome

Germany
Merck KGaA, Darmstadt, Germany

Completed

Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer (CHANGE2)

Carcinoma, Squamous Cell of Head and Neck

Germany
Institut fuer Frauengesundheit
Merck Sharp & Dohme LLC; Celgene Corporation

Completed

Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC (NIB)

Malignant Neoplasm of Breast

Germany
GE Healthcare

Terminated

Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer

Breast Cancer

United States, Belgium, Canada, France, Germany
AstraZeneca

Terminated

Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment (CHIVE)

Breast Neoplasm

Korea, Republic of, Germany, Taiwan
Aktion Bronchialkarzinom e.V.

Completed

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

Non-Small-Cell Lung Carcinoma

Germany
Johannes Gutenberg University Mainz
Interdisciplinary Center Clinical Trials (IZKS), University Medical Center...

Terminated

Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma. (CabUC)

Urothelial Carcinoma

Germany
Immatics US, Inc.

Completed

TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101) (ACTengine)

Cancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid Tumors

United States, Germany
Pierre Fabre Pharma GmbH
Winicker Norimed GmbH

Completed

Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria (StepUp)

Breast Cancer | Non-Small-Cell Lung Cancer

Germany, Austria
Johannes Gutenberg University Mainz
Interdisciplinary Center Clinical Trials (IZKS), University Medical Center...

Recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function (CaboCHILD)

Hepatocellular Carcinoma

Germany
NeoDynamics AB

Completed

Evaluation of NeoNavia® Biopsy System in Axillary Lymph Nodes (PULSE)

Breast Cancer

Germany
German Breast Group
Bayer

Completed

Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer (SOFIA)

Breast Cancer

Germany
Bayer

Completed

BAY43-9006 - Phase II in Advanced Breast Cancer

Breast Cancer | Breast Neoplasms

Italy, Germany
University Hospital Heidelberg

Terminated

Carbon Ion Radiotherapy for Hepatocellular Carcinoma (PROMETHEUS-01)

Hepatocellular Carcinoma

Germany
University of Erlangen-Nürnberg Medical School

Terminated

Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Germany
Boehringer Ingelheim
Universitätsklinikum Kiel, Onkologisches Zentrum

Recruiting

A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer

Colorectal Cancer | Pancreatic Ductal Adenocarcinoma | Non-Small-Cell Lung Carcinoma

Germany
Terumo Europe N.V.

Recruiting

Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. (HOMIE-166)

Hepatocellular Carcinoma

Germany
University of Magdeburg
Bayer; Sirtex Medical

Completed

Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer (SORAMIC)

Hepatocellular Carcinoma

Germany
Philipps University Marburg Medical Center

Withdrawn

Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Germany
University Hospital, Essen

Recruiting

Adaptive Radiotherapy in Patients With Gynecological Tumors (ProART)

Cervical Carcinoma | Radiation | Adaptive Radiotherapy | Image Guided Radiotherapy | Gynecological Tumor | Optimization | Curative Treatment | Adaptive Radiation Therapy

Germany
Medispec
Heart and Diabetes Center North-Rhine Westfalia

Unknown

Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris

Refractory Angina Pectoris

Germany
SLK Kliniken Heilbronn GmbH

Recruiting

IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients

Advanced Renal Cell Carcinoma

Germany
AIO-Studien-gGmbH

No longer available

A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer (PROCAPP)

the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine

Germany
University Hospital Regensburg
ClinAssess GmbH

Unknown

A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT (IFN_BOSZT_01)

Steroid-refractory Bronchiolitis Obliterans

Germany
AIO-Studien-gGmbH
Bristol-Myers Squibb

Completed

Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma (IMMUTACE)

Carcinoma, Hepatocellular | Hepatocellular Cancer | Hepatic Carcinoma

Germany
Novartis Pharmaceuticals

Active, not recruiting

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

Melanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal Cancer

United States, Taiwan, Spain, Germany, Japan, Hong Kong
Hoffmann-La Roche

Completed

Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC) (NIELS)

Carcinoma, Basal Cell

Germany
Tianjin Medical University Cancer Institute and...

Recruiting

Breast Mesh Used in Two-staged Breast Reconstruction

Breast Cancer | Breast Reconstruction | Radiation | Synthetic Mesh

United States, China, Germany
Charite University, Berlin, Germany
Bayer

Recruiting

Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study (HepCaSt)

MRI | HCC | Hepatocellular Carcinoma

Germany
Charite University, Berlin, Germany

Completed

InductionChemo-Radio-Antibody-Treatment (ICRAT)

Squamous Cell Carcinoma of the Neck | Squamous Cell Carcinoma of the Head

Germany
University Hospital Tuebingen

Recruiting

FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined With Immune Checkpoint Inhibition (FusionVAC22)

Fibrolamellar Hepatocellular Carcinoma

Germany
Charite University, Berlin, Germany
Klinikum rechts der Isar, TU München, (TUM), Munich, Germany.

Recruiting

Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells (HSP70CTC)

Sarcoma | Prostate Cancer | Pancreatic Cancer Stage IV | Breast Cancer Stage IV | Squamous Cell Carcinoma | Melanoma Stage IV

Germany
University Hospital Tuebingen

Unknown

Hypoxia-based Dose Escalation With Radiochemotherapy in Head and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck

Germany
Fundacao Champalimaud
European Commission; Cankado GmbH; Bocconi University; INESC TEC - Institute for... and other collaborators

Recruiting

Comparing Decision on Aesthetics After Breast Cancer Locoregional Treatment. (CINDERELLA)

Breast Cancer

Germany, Israel, Italy, Portugal, Poland
AstraZeneca

Completed

Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer. (D6090C00002)

Postmenopausal Women With ER+ HER2- Primary Breast Cancer

Germany, United Kingdom
Enrico De Toni

Recruiting

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients (MONTBLANC)

Hepatocellular Carcinoma

Germany
Institut fuer Frauengesundheit
Samsung Bioepis Co., Ltd.

Recruiting

Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON) (NeoON)

Breast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Female

Germany
GSO Global Clinical Research BV
Karyopharm Therapeutics Inc

Completed

A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (Relapsed/Refractory)

Germany
Technische Universität Dresden
German Cancer Research Center

Recruiting

A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies (CARLOTTA01)

Neoplasms | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Germany
Bayer

Terminated

Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment (SORAGO-HCC)

Hepatocellular Carcinoma

Germany
University Hospital Tuebingen
German Federal Ministry of Education and Research

Terminated

Fingerprint Characterization Tyrosine Kinase Inhibitors in Advanced HCC (e:Med-HCC-2)

Hepatocellular Carcinoma | Sorafenib

Germany
Universitätsmedizin Mannheim

Completed

Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients With Small Breast Cancer (TARGIT-E)

Neoplasms | Breast Neoplasms | Breast Diseases | Neoplasm Recurrence, Local

Germany
Ulrich Keilholz
Charite University, Berlin, Germany; AstraZeneca

Completed

Feasibility & Efficacy of Durvalumab+Tremelimumab+RT and Durvalumab+RT in Non-resect. Locally Advanced HPVnegativ HNSCC (DURTRE-RAD)

Squamous Cell Carcinoma of the Head and Neck

Germany

Clinical Trials on Refractory Breast Carcinoma in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations